United States Immunostimulatory Adjuvants Market Report 2017

December 2017 | 100 pages | ID: U4BB4102467EN
QYResearch

Abstracts

In this report, the United States Immunostimulatory Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Immunostimulatory Adjuvants in these regions, from 2012 to 2022 (forecast).

United States Immunostimulatory Adjuvants market competition by top manufacturers/players, with Immunostimulatory Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Recenttec
• Bayer
• Adjuvance Technologies
• Vical
• Allergy Therapeutics
• BioCentury

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Freund Adjuvant
• Aluminum Hydroxide Adjuvant
• Alum Adjuvant
• Liposomes
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Medical Center
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Immunostimulatory Adjuvants Market Report 2017

1 IMMUNOSTIMULATORY ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Immunostimulatory Adjuvants
1.2 Classification of Immunostimulatory Adjuvants by Product Category
  1.2.1 United States Immunostimulatory Adjuvants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Immunostimulatory Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Freund Adjuvant
  1.2.4 Aluminum Hydroxide Adjuvant
  1.2.5 Alum Adjuvant
  1.2.6 Liposomes
  1.2.7 Others
1.3 United States Immunostimulatory Adjuvants Market by Application/End Users
  1.3.1 United States Immunostimulatory Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Medical Center
  1.3.4 Others
1.4 United States Immunostimulatory Adjuvants Market by Region
  1.4.1 United States Immunostimulatory Adjuvants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Immunostimulatory Adjuvants Status and Prospect (2012-2022)
  1.4.3 Southwest Immunostimulatory Adjuvants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Immunostimulatory Adjuvants Status and Prospect (2012-2022)
  1.4.5 New England Immunostimulatory Adjuvants Status and Prospect (2012-2022)
  1.4.6 The South Immunostimulatory Adjuvants Status and Prospect (2012-2022)
  1.4.7 The Midwest Immunostimulatory Adjuvants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Immunostimulatory Adjuvants (2012-2022)
  1.5.1 United States Immunostimulatory Adjuvants Sales and Growth Rate (2012-2022)
  1.5.2 United States Immunostimulatory Adjuvants Revenue and Growth Rate (2012-2022)

2 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Immunostimulatory Adjuvants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Immunostimulatory Adjuvants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Immunostimulatory Adjuvants Average Price by Players/Suppliers (2012-2017)
2.4 United States Immunostimulatory Adjuvants Market Competitive Situation and Trends
  2.4.1 United States Immunostimulatory Adjuvants Market Concentration Rate
  2.4.2 United States Immunostimulatory Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Immunostimulatory Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Immunostimulatory Adjuvants Sales and Market Share by Region (2012-2017)
3.2 United States Immunostimulatory Adjuvants Revenue and Market Share by Region (2012-2017)
3.3 United States Immunostimulatory Adjuvants Price by Region (2012-2017)

4 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Immunostimulatory Adjuvants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Immunostimulatory Adjuvants Revenue and Market Share by Type (2012-2017)
4.3 United States Immunostimulatory Adjuvants Price by Type (2012-2017)
4.4 United States Immunostimulatory Adjuvants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Immunostimulatory Adjuvants Sales and Market Share by Application (2012-2017)
5.2 United States Immunostimulatory Adjuvants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Recenttec
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Recenttec Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Adjuvance Technologies
  6.3.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Adjuvance Technologies Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Vical
  6.4.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Vical Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Allergy Therapeutics
  6.5.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Allergy Therapeutics Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 BioCentury
  6.6.2 Immunostimulatory Adjuvants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 BioCentury Immunostimulatory Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 IMMUNOSTIMULATORY ADJUVANTS MANUFACTURING COST ANALYSIS

7.1 Immunostimulatory Adjuvants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Immunostimulatory Adjuvants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Immunostimulatory Adjuvants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Immunostimulatory Adjuvants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES IMMUNOSTIMULATORY ADJUVANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Immunostimulatory Adjuvants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Immunostimulatory Adjuvants Sales Volume Forecast by Type (2017-2022)
11.3 United States Immunostimulatory Adjuvants Sales Volume Forecast by Application (2017-2022)
11.4 United States Immunostimulatory Adjuvants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Immunostimulatory Adjuvants
Figure United States Immunostimulatory Adjuvants Market Size (K MT) by Type (2012-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume Market Share by Type (Product Category) in 2016
Figure Freund Adjuvant Product Picture
Figure Aluminum Hydroxide Adjuvant Product Picture
Figure Alum Adjuvant Product Picture
Figure Liposomes Product Picture
Figure Others Product Picture
Figure United States Immunostimulatory Adjuvants Market Size (K MT) by Application (2012-2022)
Figure United States Sales Market Share of Immunostimulatory Adjuvants by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Medical Center Examples
Table Key Downstream Customer in Medical Center
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Immunostimulatory Adjuvants Market Size (Million USD) by Region (2012-2022)
Figure The West Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunostimulatory Adjuvants Sales (K MT) and Growth Rate (2012-2022)
Figure United States Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Immunostimulatory Adjuvants Market Major Players Product Sales Volume (K MT) (2012-2017)
Table United States Immunostimulatory Adjuvants Sales (K MT) of Key Players/Suppliers (2012-2017)
Table United States Immunostimulatory Adjuvants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunostimulatory Adjuvants Sales Share by Players/Suppliers
Figure 2017 United States Immunostimulatory Adjuvants Sales Share by Players/Suppliers
Figure United States Immunostimulatory Adjuvants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Immunostimulatory Adjuvants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Immunostimulatory Adjuvants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Immunostimulatory Adjuvants Revenue Share by Players/Suppliers
Figure 2017 United States Immunostimulatory Adjuvants Revenue Share by Players/Suppliers
Table United States Market Immunostimulatory Adjuvants Average Price (USD/MT) of Key Players/Suppliers (2012-2017)
Figure United States Market Immunostimulatory Adjuvants Average Price (USD/MT) of Key Players/Suppliers in 2016
Figure United States Immunostimulatory Adjuvants Market Share of Top 3 Players/Suppliers
Figure United States Immunostimulatory Adjuvants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Immunostimulatory Adjuvants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Immunostimulatory Adjuvants Product Category
Table United States Immunostimulatory Adjuvants Sales (K MT) by Region (2012-2017)
Table United States Immunostimulatory Adjuvants Sales Share by Region (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Share by Region (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Market Share by Region in 2016
Table United States Immunostimulatory Adjuvants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Immunostimulatory Adjuvants Revenue Share by Region (2012-2017)
Figure United States Immunostimulatory Adjuvants Revenue Market Share by Region (2012-2017)
Figure United States Immunostimulatory Adjuvants Revenue Market Share by Region in 2016
Table United States Immunostimulatory Adjuvants Price (USD/MT) by Region (2012-2017)
Table United States Immunostimulatory Adjuvants Sales (K MT) by Type (2012-2017)
Table United States Immunostimulatory Adjuvants Sales Share by Type (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Share by Type (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Market Share by Type in 2016
Table United States Immunostimulatory Adjuvants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Immunostimulatory Adjuvants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Immunostimulatory Adjuvants by Type (2012-2017)
Figure Revenue Market Share of Immunostimulatory Adjuvants by Type in 2016
Table United States Immunostimulatory Adjuvants Price (USD/MT) by Types (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Growth Rate by Type (2012-2017)
Table United States Immunostimulatory Adjuvants Sales (K MT) by Application (2012-2017)
Table United States Immunostimulatory Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Market Share by Application in 2016
Table United States Immunostimulatory Adjuvants Sales Growth Rate by Application (2012-2017)
Figure United States Immunostimulatory Adjuvants Sales Growth Rate by Application (2012-2017)
Table Recenttec Basic Information List
Table Recenttec Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Recenttec Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure Recenttec Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure Recenttec Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bayer Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure Bayer Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure Bayer Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table Adjuvance Technologies Basic Information List
Table Adjuvance Technologies Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Adjuvance Technologies Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure Adjuvance Technologies Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure Adjuvance Technologies Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table Vical Basic Information List
Table Vical Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Vical Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure Vical Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure Vical Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table Allergy Therapeutics Basic Information List
Table Allergy Therapeutics Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergy Therapeutics Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure Allergy Therapeutics Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure Allergy Therapeutics Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table BioCentury Basic Information List
Table BioCentury Immunostimulatory Adjuvants Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure BioCentury Immunostimulatory Adjuvants Sales Growth Rate (2012-2017)
Figure BioCentury Immunostimulatory Adjuvants Sales Market Share in United States (2012-2017)
Figure BioCentury Immunostimulatory Adjuvants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immunostimulatory Adjuvants
Figure Manufacturing Process Analysis of Immunostimulatory Adjuvants
Figure Immunostimulatory Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Immunostimulatory Adjuvants Major Players/Suppliers in 2016
Table Major Buyers of Immunostimulatory Adjuvants
Table Distributors/Traders List
Figure United States Immunostimulatory Adjuvants Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Immunostimulatory Adjuvants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Immunostimulatory Adjuvants Price (USD/MT) Trend Forecast (2017-2022)
Table United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Type (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Type in 2022
Table United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Application (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Application in 2022
Table United States Immunostimulatory Adjuvants Sales Volume (K MT) Forecast by Region (2017-2022)
Table United States Immunostimulatory Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Immunostimulatory Adjuvants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources